Rationale: MicroRNA-499 and other members of the myomiR family regulate myosin isoforms in pressure-overload hypertrophy. miR-499 expression varies in human disease, but results of mouse cardiac miR-499 overexpression are inconsistent, either protecting against ischemic damage or aggravating cardiomyopathy after pressure overload. Likewise, there is disagreement over direct and indirect cardiac mRNAs targeted in vivo by miR-499. Objective: To define the associations between regulated miR-499 level in clinical and experimental heart disease and modulation of its predicted mRNA targets and to determine the consequences of increased cardiac miR-499 on direct mRNA targeting, indirect mRNA modulation, and on myocardial protein content and posttranslational modification. Methods and Results: miR-499 levels were increased in failing and hypertrophied human hearts and associated with decreased levels of predicted target mRNAs. Likewise, miR-499 is increased in Gq-mediated murine cardiomyopathy. Forced cardiomyocyte expression of miR-499 at levels comparable to human cardiomyopathy induced progressive murine heart failure and exacerbated cardiac remodeling after pressure overloading. Genome-wide RNA-induced silencing complex and RNA sequencing identified 67 direct, and numerous indirect, cardiac mRNA targets, including Akt and MAPKs. Myocardial proteomics identified alterations in protein phosphorylation linked to the miR-499 cardiomyopathy phenotype, including of heat shock protein 90 and protein serine/threonine phosphatase 1-␣.
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Editorial, see p 506 miR-499 is highly expressed in hearts, but the mRNA of its parent Myh7b gene is not. 1, 3, 4 miR-499 is encoded within intron 19 of Myh7b, a sarcomeric myosin gene expressed in skeletal muscle but not significantly in hearts. 5 Cardiac miR-499 expression is uncoupled from Myh7b by alternative splicing of the primary transcript; Myh7b mRNA is eliminated by nonsense-mediated decay, whereas miR-499 is protected by nuclear export. 5 The observation that hearts retain and dynamically regulate miR-499 at the expense of first transcribing, and then actively eliminating the parent Myh7b mRNA, suggests an important function in this organ.
We describe miR-499 upregulation in diseased human and mouse hearts that is disproportionate to regulation of other myomiRs. We show that a number of bioinformatically defined miR-499 target mRNAs are counterregulated in the same samples. Using a combination of unbiased genomewide "omics" approaches, we define direct and indirect targets of miR-499, uncovering higher-order effects not predicted by standard bioinformatics approaches and revealing systemic control by miR-499 over protein phosphorylation pathways.
Methods miR and mRNA Expression Analysis in Human and Murine Cardiomyopathy Using Microarrays
Methods have been described previously. 4, 6, 7 Full details are in the Online Data Supplement.
Generation and Characterization of miR-499 Transgenic Mice
miR-499 transgenic mice were created as described 8 ; the studies here utilize the previously described mouse, designated line 1 8 and referred to as TG-16 here, and 2 novel lines. Mice were housed according to procedures approved by the Washington University Institutional Animal Care and Use Committee. miR-499 expression was measured using NCode miR RT-qPCR system (Invitrogen) and detected using Sybr GreenER (Invitrogen). Histological examination, M-mode echocardiography of nonsedated mice, and surgical transverse aortic constriction were carried out according to standard techniques. 9 Identification and quantification of RNA-induced silencing complex (RISC)-associated mRNAs and cardiac transcriptional profiling by high-throughput sequencing was performed as described. 7, 10 Highly detailed experimental protocols are in the Online Data Supplement, including the Appendix on RNA sequencing.
Proteomics and Phosphoproteomics
Two-dimensional DiGE (differential in-gel electrophoresis) total protein, and phosphoproteome analyses, together with mass spectrometric protein identification, were performed as described 11 at Applied Biomics (Hayward, CA), using 5 pairs of nontransgenic and miR-499 TG-16 mouse hearts. Studies were performed at 8 weeks of age (at a time when miR-499 cardiomyopathy was evident by echocardiographic examination but before overt heart failure had developed) and at 1 week after surgical transverse aortic coarctation. Detailed experimental protocols are in the Online Data Supplement.
Statistical and Informatics Analysis
Unless otherwise specified, all data are presented as meanϮSEM, and probability values were calculated using Student unpaired t test (for 2 groups) or 1-way ANOVA (for more than 2 groups). Statistical significance was taken at PϽ0.05. Comparison of transcriptomic data sets, including calculation of false discovery rates, was performed using Partek Genomics Suite 6.5; significance was taken at PϽ0.005 (false discovery rate Ͻ0.05). Gene-ontology analysis was performed using BiNGO. 12 The online software suite MetaCore 13 was also used to perform gene characterization and enrichment analyses; data herein derive from proprietary "Pathway Maps," "Process Networks," and "Enrichment by Protein Function" modules. Full procedures for conversion of raw sequence reads to mRNA expression data are detailed in the Online Data Supplement in the Appendix on RNA sequencing.
Results

MyomiRs Are Increased in Human and Experimental Cardiomyopathy and Downregulate Cardiac mRNA Targets
MyomiRs are reportedly upregulated in human heart failure as part of a broader genetic program involving dozens of miRs and mRNAs. 4, 14 Many such studies use "failing" samples from explanted hearts at the time of transplantation, compared with "nonfailing" hearts harvested, but not used, for transplantation. Importantly, nonfailing is not necessarily "normal," and we have noted that hypertrophied nonfailing human hearts have an abnormal gene expression signature. 4 In the present study, we compared myomiR levels in normal, failing, and 2 available nonfailing hypertrophied hearts. Compared with miR-208 (a and b) ( Figure 1A , left), miR-499 was more aggressively upregulated in heart failure and hypertrophy ( Figure 1A , right, blue circles and red triangles, respectively). Measurable miR-499 parent Myh7b transcript was also increased ( Figure 1B , blue circles). Although the number of hypertrophied/ nonfailing samples is insufficient for statistical comparisons, these data suggest that miR-499 is upregulated in clinical hypertrophy and heart failure.
We examined the human heart transcriptomes for evidence of biological effects of increased miR-499. Recognizing that counterregulation of target mRNAs is potentially influenced by other factors, we nevertheless considered that absence of such counterregulation would show that miR-499 levels had little impact on the human condition. Steady-state levels of 98 cardiac-expressed miR-499 mRNA targets predicted by Target-Scan6 15 were significantly (PϽ0.05) depressed in the same cardiomyopathic human hearts ( Figure 1C and Online Table I ). Thus, miR-499 and its parent Myh7b transcript are increased in human cardiomyopathy, and miR-499 upregulation is associated with downregulation of putative cardiac mRNA targets.
The cardiac G␣q-overexpressing mouse is a genetic model of cardiomyopathy that recapitulates seminal aspects of pressureoverload hypertrophy. 16, 17 To determine if increased miR-499 was a cell-autonomous response to a cardiomyocyte-specific cardiomyopathic stimulus, we performed miR microarray analyses on hearts of 4 G␣q transgenic mice and 4 littermate controls. 6 miR-499 was increased 2.7-fold over control levels in G␣q hearts and was the second most highly regulated mi-croRNA in this model ( Figure 1D ). Cardiac miR-499 upregulation was validated in a separate G␣q cohort using miR RT-qPCR ( Figure 1E ). Thirteen cardiac miR-499 mRNA targets 7 were correspondingly downregulated ( Figure 1F ), including the counterregulated human heart failure miR-499 target, Sos2 ( Figure  1F , asterisk).
Forced Cardiac miR-499 Expression Induces Heart Failure in Mice
Previous mouse transgene expression studies have described both miR-499 mediated cardioprotection from ischemic injury 2 and miR-499 mediated induction and exacerbation of heart failure. 3 Based on these results and our own observation that miR-499 is increased in heart disease, the conclusion is either that miR-499 is protective or detrimental. To help resolve this debate, we forced expression of miR-499 in 3 independent lines of transgenic mouse hearts: 2 lines with levels observed in Table II ). Ventricular cardiomyocyte cross-sectional area increased in all three miR-499 transgenic lines ( Figure 2D ). Fibrosis was not a major component of the unstressed miR-499 phenotype, although limited areas of interstitial collagen were observed in aging mice of miR-499 TG-53 (Online Figure II) . miR-499 induced genetic reprogramming typical of murine cardiac hypertrophy/heart failure 18 ( Figure 3A ). Of hundreds of mRNAs altered in either 4-week-old or 8-week-old miR-499 hearts, we identified 136 mRNAs that are concordantly regulated at both time points (thus filtering out the transcriptional background of normal postnatal heart growth). 19 These results were consistent across individual mice, by genotype and over time ( Figure 3B and Online Table III ). We designated this subset of regulated mRNAs as those primarily affected (either directly or indirectly) by miR-499. Gene-ontology anal-ysis revealed major effects on Development and Formation of Cytoskeletal Elements (annotated as Biopolymers) (Online Figure III ). Among the downregulated primarily affected mRNAs were 31 identified by TargetScan6 as potential direct miR-499 targets, 4 of which had been downregulated in G␣q transgenic hearts ( Figure 3C and Online Table IV) and 7 of which had been downregulated in human cardiomyopathy ( Figure 3C , asterisks). We 7,20 and others 21, 22 have demonstrated the superiority of RNA sequencing over microarray and RT-qPCR methods for precision, dynamic range, and high-throughput characterization. Nonetheless, we validated 3 of these mRNAs using Taq-Man RT-qPCR ( Figure 3D ). Thus, at levels observed in human disease, miR-499 induces heart failure in mice and counterregulates many of the same predicted mRNA targets.
We also examined how increased miR-499 levels influence disease progression after transverse aortic constriction (TAC). TAC produced left ventricular remodeling in both miR-499 and nontransgenic mice ( Figure 4A and 4B), but only miR-499 mice developed left ventricular dysfunction ( Figure 4B ). Correspond- Table I ). Four representative hearts each are shown for nonfailing (NF), and failing hearts with cardiomyopathy of ischemic origin (isch) or nonischemic origin (nonisch). Red indicates higher expression; blue, lower expression. D, miR microarray analysis of G␣q transgenic hearts, 6 displaying miRs according to degree of upregulation (Ն1.2-fold, PϽ0.05; miR-451, 4.4 fold-upregulated in Gq, is at the top). E, miR-499 analyzed by RT-qPCR relative to combined reference of 5S rRNA, U6 snRNA, and Gapdh mRNA 57 in nontransgenic (nϭ3) and G␣q hearts (nϭ6). Data shown are meanϮSEM, arbitrary units (nontransgenicϭ1); *Pϭ0.0006, 2-tailed unpaired t test. F, Downregulation of 13 miR-499 target mRNAs, predicted by TargetScan (Ͼ1.2-fold downregulation, PϽ0.05) in G␣q transcriptomes analyzed by RNA sequencing. 7 Red indicates higher expression; blue, lower expression. *Downregulation of the same mRNA in human heart failure.
ing deleterious effects of miR-499 on the response to TAC were observed at the organ and cellular levels: heart weight-to-body weight ratios were higher ( Figure 4C) , cardiomyocyte crosssectional area was greater ( Figure 4D ), and myocardial fibrosis was more extensive ( Figure 4E ).
Transcriptional profiling of nontransgenic and miR-499 transgenic mice 1 week after TAC surgery interrogated molecular mechanisms of adverse cardiac remodeling. Because TAC surgery was performed on 8-week-old mice and the miR-499 induced cardiomyopathy was developing at this age, the transcriptional signature of TAC miR-499 mice should reflect 3 separate events: (1) direct effects of miR-499 overexpression (see above); (2) secondary effects of the developing cardiomyopathy, and (3) the response to pressure overload superimposed on (1) and (2) . Unexpectedly, the most revealing comparison of transcript signatures was between TAC nontransgenic mice (626 regulated mRNAs) and sham-operated miR-499 mice (1168 regulated mRNAs): 290 mRNAs were similarly regulated. Principal components analysis showed the expected genetic reprogramming in pressure-overloaded nontransgenic mice, but the mRNA profile of miR-499 transgenic mice overlapped substantially with that of TAC, regardless of genotype ( Figure  4F ). The only statistically significant additional effect of pressure overloading on miR-499 hearts was hyper-upregulation of Pi3kr1. Unsupervised hierarchical clustering of regulated mRNAs distinguished sham from pressure-overloaded nontransgenic groups but was unable to resolve miR-499 transgenic sham and pressure-overloaded groups (Online Figure IV) . These findings reveal similar cardiac gene reprogramming by miR-499 and pressure overload and confirm and extend previously reported detrimental effects of miR-499 on TAC mouse hearts. 3
Functional Analysis of Direct and Indirect miR-499 mRNA Targets
MicroRNAs exert their end-organ effects via suppression of direct mRNA targets and by secondary and tertiary effects that accrue through so-called "indirect" targets. It is therefore not surprising that many miR-499 -regulated mRNAs were not bioinformatically identified as direct mRNA targets. 15 To better understand the relationship between miR-499 function and phenotype, we used agnostic whole-genome RISC sequencing to identify relevant mRNA targets of miR-499 in normal mouse hearts. 10, 23 RISC-associated mRNAs were quantified in 4-weekold mice of miR-499 TG-16 (an age when heart size and function are normal, thus avoiding potential confounding effects of age-related cardiomyopathy) (see Figure 2B ). Sixty-three mRNAs were enriched by 25% or greater in miR-499 -programmed cardiac RISCs ( Figure 5A and Online Table V) , including the validated miR-499 target, Sox6. 1, 5 By extending our filtering criteria to include any mRNAs increased by Ͼ3-fold in RISComes alone, we identified another 4 miR-499 targets, including Med13 (Thrap1), 5 which functions in ␣MHC/ ␤MHC isoform switching. 24 TG-53, expressing 3-fold greater miR-499, exhibited only twice (or less) RISC enrichment of these mRNA targets, compared with TG-16, revealing a nonlinear relationship between miR-499 level, RISC targeting (ie, RISC saturation).
miR-mediated destabilization of targeted mRNA can depress steady-state mRNA levels. 25, 26 Indeed, levels of approximately one-fourth of the miR-499 RISC-enriched mRNAs were significantly depressed in the corresponding miR-499 transgenic hearts ( Figure 5B and Online Table VI) . A small number 8 of miR-499 RISC-targeted mRNAs showed increased steady-state levels, reflecting either indirect effects or atypical miR-target interactions 27 (Figure 5B ). The physical location of miR-499 binding sites within these biologically defined mRNA targets was identified through sequence complementarity; most were localized within 3ЈUTRs ( Figure 5C ).
Gene-ontology analysis uncovered functional overlap between the 67 direct miR-499 target mRNAs identified by RISC-Seq and the 136 indirectly regulated, primarily affected mRNAs detected by RNA-Seq (see Figure 3B ). The GO categories of Development and Formation of Cytoskeletal Elements plus the additional category of Regulation of RNA Polymerase II-Dependent Transcription were significantly enriched (using BiNGO 12 ) (Online Figure III) . A more detailed molecular function analysis of protein functional categories (eg, kinases, phosphatases, enzymes, transcription factors, proteases, ligands, and receptors) (using MetaCore 13 ), identified 1 hyper-enriched (Pϭ0.0004) functional class of direct miR-499 mRNAs: Kinases. Eight of the 67 direct miR-499 target mRNAs are kinases: Bmp2k, Cpne3, Hipk1, Hipk2, Map3k2 (Mekk2), Stk35, Taok1, and Uhmk1. Both Hipk1 and Hipk2 are nuclear-localized protein serine/threonine kinases whose regulation can affect transcription. 28 Because only a small proportion of miR-499 -regulated mR-NAs are direct targets recruited to the RISC, we assessed the ontological function of the 1168 mRNAs secondarily regulated in the developing cardiomyopathy induced by miR-499 (Online Figure IV) . MetaCore "Pathway Maps" and "Process Networks" analysis identified increased representation of mRNAs in Cytoskeletal Remodeling, TGF, and Wnt pathways in miR-499 hearts (and also in TAC hearts; Online Table VII ). MEF2-related signaling, which is a central transcriptional regulator of cardiac hypertrophy, 29 was also markedly regulated by miR-499. Strikingly, the only significantly enriched MetaCore "Molecular Function" category was kinases (Online Table VIII ): 33 kinase mRNAs were upregulated and 6 were downregulated (Online Table IX ). Those miR-499 -regulated mRNAs that were similarly regulated in pressure overload (Online Figure IV) were also enriched in kinases (Online Table IX ). (mRNAs distinctly regulated by pressure overload were not enriched in any molecular function category but were significantly disenriched for the category of receptors [Online Table IX ].) Of note, the prosurvival kinase Akt was centrally impacted by miR-499. Akt itself is downregulated by miR-499, whereas the phosphatase Pten (which dephosphorylates the upstream Akt activator PtdIns [3,4,5]P 3 ) and the phosphatase Phlpp1 (which dephosphorylates and inactivates Akt at Ser473) 30 were increased (Online Table  IX ). Another key cardiac kinase, CaMKII␦, 31 is downregulated in miR-499 transgenic hearts. By contrast, several elements of mitogen-activated protein kinase cascades (Map2k3, Map3k5, Map3k6, Map4k2, Map4k4, Mapk14, and Mknk2) are upregulated (Online Table IX ). Thus, miR-499 exerts major direct and indirect effects on cardiac protein kinase and phosphatase expression.
Higher-Order miR-499 Effects on the Cardiac Proteome and Phosphoproteome
We determined the (primary and secondary) proteomic consequences of transcriptional reprogramming by miR-499 using 2-dimensional differential in-gel electrophoresis (DiGE). 11, 32 Proteomics analyses were performed on 8-week-old mouse hearts to compare with the pressure overload studies (see above). DiGE is an agnostic measure of cardiac protein content but detects the most highly expressed myocardial proteins. 33 Of Ϸ1000 distinct protein spots (representing different proteins, protein isoforms, or posttranslationally modified forms) quantified in 5 independent paired analyses, 27Ϯ2% were regulated 20% or greater by miR-499 transgene (12% upregulated; 15% downregulated) (Online Figure V) . Forty-six regulated protein spots matched between all 5 paired analyses were identified by mass spectroscopy (nϭ31) or manual comparison to published proteomic maps (nϭ15) (Figure 6 , Online Table X, and Online Figure V ). Of these, the protein products of Ckmt2, Mdh1, Mybpc3 (MyBP-C), Pdha1, and P4hb consisted of multiple spots corresponding to posttranslationally modified species, 34 -36 including differential phosphorylation for MyBP-C 11 and Pdha1 37 ( Figure 6 and Online Figure V) . mRNA and protein expression data were available for 30 individual unambiguously defined gene products (excluding the 5 that migrated as multiple species). Six of these were concordantly regulated at the mRNA and protein level, whereas 8 exhibited no change in mRNA or protein in miR-499 transgenic hearts, compared with nontransgenic hearts (Figure 6 ). Eleven additional gene products were unchanged at the mRNA level but downregulated by miR-499 in the protein studies ( Figure 6 ), and 5 gene products exhibited opposing regulation of steady-state mRNA and protein ( Figure 6 ). We performed parallel proteomic profiling 1 week after TAC surgery. There were few differences between miR-499 transgenic and nontransgenic experiments in the proteins we identified (Online Table XI) .
Given the observed miR-499 regulation of kinase and phosphatase pathways mRNAs, we compared in a 2ϫ2 design the cardiac phosphoproteomes of nontransgenic and miR-499 mice at baseline and 1 week after pressure overloading by TAC (Figure 7 and Online Figure VI) . Five strikingly regulated phosphoproteins, and one which did not change between treatments (Ehd2), were detected and identified using mass spectrometry (Online Table XII ). Phosphor-ylation of the chaperone protein heat shock protein 90 (HSP90)␤ (Hsp90ab1) was modified in sham-operated miR-499 transgenic hearts ( Figure 7C and Online Table XII) ; corresponding HSP90␤ total protein and mRNA levels were unchanged (Online Table XII ). Phosphorylation of protein phosphatase 1␣ (Ppp1ca) was markedly increased in pressureoverloaded miR-499 transgenic mouse hearts; protein serine/ threonine phosphatase 1-alpha (PP1␣) phosphorylation was nearly undetectable in the other groups, and its mRNA levels did not change. As we identified HSP90␤ and PP1␣ phosphoproteins using mass spectrometry, the differential phosphorylation of Hsp90␤ and PP1␣ was confirmed using 2D PAGE followed by immunoblotting ( Figure 7B ) and the immunoblot gels compared with phosphoprotein gels (Figure 7C and 7D) . Ndufa10 (a complex I subunit) phosphorylation resembled that of PP1␣. Pgm2 (phosphoglucomutase-2) phosphorylation was decreased in nontransgenic TAC hearts, without change in mRNA; Gpd1 (glycerol-3-phosphate dehydrogenase 1) phosphorylation was increased in nontransgenic TAC hearts and sham-operated miR-499 transgenic hearts (Online Table XII ).
Discussion
In these studies of human heart failure and transgenic mice, we provide evidence that upregulation of miR-499 contributes to pathological aspects of heart failure through direct regulation of approximately 70 individual primary mRNA targets and indirect regulation of a large number of cardiac mRNAs and proteins. miR-499 levels are increased in human heart failure and the mouse G␣q transgenic model of cardiomyopathy, its forced expression at similar levels to human heart failure in normal mouse hearts induces cardiomyopathy, and increased miR-499 levels adversely affect the response to pressure overload of mouse hearts. These results support a pathological role for miR-499 in the heart, consistent with previous associative studies 4, 5 and observations in 2 lines of miR-499 transgenic mice created by the Srivastava laboratory. 3 Our studies demonstrate that the genetic reprogramming induced by miR-499 upregulation recapitulates many aspects of pathological cardiac hypertrophy at the transcriptional, cellular, and organ level. Whole-transcriptome analysis by RNA sequencing showed a marked overlap between the profiles of pressure-overloaded hearts and those expressing miR-499, whereas the increase in myocyte size and decline in contractile performance characteristic of the hypertrophying heart could be induced by miR-499 overexpression alone. Since miR-499 levels were also increased in hypertrophied, nonfailing human and murine G␣q transgenic hearts, it appears that some pathological aspects of reactive hypertrophy are conferred, at least in part, by miR-499. Our observations elucidate novel mechanisms by which miR-499 can contribute to cardiac disease but do not suggest that inhibiting miR-499 would have therapeutic efficacy. Previous studies have determined that miR-499 is functionally redundant with another myomiR, miR-208b. 1 For this reason, increased expression of either of these miRs can contribute to cardiac pathology, but both would need to be inhibited to prevent that pathology. Indeed, expression of both miR-208b and miR-499 is indirectly controlled by miR-208a, and anti-miR therapy directed against miR-208a was recently shown to improve experimental hypertrophy. 38 We integrated results of unbiased transcriptome and proteomic analyses to uncover a striking feature of miR-499 -induced heart disease; regulation of pathways that orchestrate posttranslational protein modification. Wang et al implicated miR-499 translational suppression of the cardiac hypertrophy effector phosphatase, calcineurin in posttranslational modification of the mitochondrial fission protein, dynamin-related protein 1 (Drp1). 2 Our unbiased comprehensive examination of direct and indirect miR-499 targets likewise suggests that many effects of this miR are mediated via regulation of kinase/ phosphatase pathways (Figure 8 ). Kinases regulated directly and indirectly by miR-499, together with the observed altered phosphorylation of the key signaling proteins HSP90␤ and PP1␣, influence mitogen-activated protein kinase (MAPK) cascades, control of mRNA translation, Ca 2ϩ transport, and cell survival ( Figure 8 ).
HSP90␤ phosphorylation was directly affected by miR-499 (ie, was altered in the absence of TAC). Constitutively expressed HSP90␤ is expressed at higher levels than stressinducible HSP90␣ (gene symbol Hsp90aa1) in both heart and skeletal muscle. 3940 Interestingly, Hsp90aa1 mRNA was upregulated 1.5-fold by pressure overload alone (Online Table XII ). Interactions of the HSP90 proteins with their cochaperones and signaling proteins (such as Cdc37 41 and PP5 42 ) is regulated by phosphorylation. 43 Cardiac signaling most affected by HSP90 includes the p38 MAP kinase pathway 41 and the cardiac ERG potassium channel. 44 Importantly, HSP90 controls signaling through the "physiological hypertrophy" PI3K/Akt signaling axis by stabilizing both Akt 45 and its activating upstream kinase Pdpk1. 46 HSP90 may also directly affect miR functioning by facilitating maturation and targeting of Ago2 to P-bodies and miR-loaded RISC complexes 47 ; the extent to which these processes are affected by HSP90 phosphorylation has not been determined.
In contrast to modulation of HSP90␤ phosphorylation by miR-499, PP1␣ phosphorylation was only strongly detected with the combination of TAC and miR-499 overexpression. The ability of PP1␣ to dephosphorylate substrates and regulate signal transduction depends on the presence of appropriate adapter proteins that target PP1␣ to macromolecular complexes, 48 but its phosphorylation interferes with its catalytic activity. 49 Cardiac phosphoproteins regulated by PP1␣ include RyRs, 50 phospholamban, 51 IP 3 Rs, 52 and the sodium/calcium exchanger Ncx1. 53 Although the current results have provided fresh insight into the effects of miR-499 on the heart and uncovered new mechanisms for those effects, a more general aim of our laboratory is to deploy more effective techniques for analyzing and understanding the consequences of regulated miRs in heart disease. As many miRs are encoded within introns of parent genes, and others have their own transcriptional regulatory mechanisms, it is not surprising that regulated expression of miRs occurs under many of the same circumstances as regulated expression of protein-coding mRNAs. We previously described concurrent regulation of miR and mRNAs in human heart failure and observed that miRs appear more sensitive to the functional dynamics of heart failure clinical status. 4 Similar observations, 54 and the more recent finding that miR are released into the blood stream and may serve as both signatures and systemic mediators of cardiac disease, 55 have further catalyzed interest in defining the roles of individual miRs in the heart and other tissues. However, the convoluted targeting patterns of miRs, in which the effects of a single miR on multiple targets are multiplied through secondary and tertiary indirect effects, complicate their in vivo analysis. As an example, myomiRs are best known by their critical actions regulating cardiac myosin isoform expression in response to stress or hormonal factors, 1,24 yet our studies did not identify mRNAs for either Myh6 or Myh7 as RISCenriched after miR-499 programming. In other words, these 2 major targets of myomiRs are not directly recruited by miR-499 for destruction in the cardiac RISC but represent indirect targets affected through secondary or tertiary mechanisms. This is consistent with Bartel's 56 observation that "The (miR) responsive proteins are not necessarily the endogenous (miR) targets, and the magnitude and kinetics of mRNA and protein changes are not expected to match those of endogenous targeting." The majesty of microRNAs, and the potential utility of targeting them in disease, is their ability to regulate entire biological pathways in this way. We suggest that the reductionist paradigm of 1 molecule affecting 1 target that causes a given phenotype does not typically apply to miRs.
Despite similar cardiac phenotypes in response to miR-499 overexpression, our mRNA analyses reveal several differences to the studies of Shieh et al. 3 Indeed, we 7 and others 21 have described greater specificity and accuracy of RNA sequencing over RNA microarrays, and it is likely that some of the discrepancies between the description of cardiac miR-499 mRNA targets by Shieh et al 3 and the current study derive from our different approaches to mRNA analysis (Online Tables XIII and XIV) and potentially the difference in age of the mice used (postnatal day 17 compared with 4 week-old animals). Evidence of our technical advantage in RNA analysis includes our observation that the well-described in vitro miR-499 target, Sox6, is indeed both recruited to the RISCs and downregulated in miR-499 overexpressing hearts, whereas Shieh et al's microarray analysis, and qPCR and immunoblot analyses relating Sox6 to Gapdh, did not detect downregulation of Sox6 in their miR-499 hearts. 3 We previously observed that Sox6 is highly enriched in the RISCs of nontransgenic hearts (as expected from high endogenous miR-499 expression levels) 10 and is further recruited to the RISCs of miR-499 transgenic hearts, although as previously discussed, 10 our more stringent selection criteria in the earlier study excluded Sox6 from a miR-499-programmed, RISC-enriched gene list.
Although an agnostic, biologically driven approach has many advantages, we would like to emphasize certain limitations of RNA sequencing and Argonaute 2 immunoprecipitation as employed herein. First, RISC programming by transgenic miR overexpression has the potential to express both the mature miR and its complement (miR*). If the overexpressed miR* is not eliminated in a normal manner, then it will recruit its targets to the RISC, which will be detected by RISC sequencing. In our studies, we use RT-qPCR to measure the miR and miR* products of each tissue assayed; in the case of miR-499, we find that miR-499* (miR-499 -3p) is expressed at levels Ϸ600-fold below that of miR-499(-5p) and that this ratio remains similar in miR-499 transgenic mice (Yuanxin Hu and Gerald Dorn, unpublished data). Second, we think that overexpressing miRs that are already expressed at high levels may not be as effective in revealing their targets as RISC programming with miRs expressed at more modest levels, because at some level miR-mRNA incorporation into the RISC will approach saturation. Indeed, saturability of the RISC with highly expressed miRs may explain the nonlinear relationship between miR-499 expression level and phenotypic effect in our low-and high-expressing transgenic mice (Figures 2 and 5 ). Finally, it is conceivable that the expression level of other miRs will be altered by miR overexpression (or ablation), which will alter the RISCome accordingly. This scenario would incorrectly identify some RISC-enriched mRNAs as direct targets of the RISCprogramming miR.
In summary, we have shown that miR-499 is highly upregulated in human heart disease, that forced cardiomyocyte miR-499 expression is sufficient to induce progressive heart failure in mice, and that elevated miR-499 expression is deleterious in the context of pressure overload. The end-organ effects of miR-499 are complex, reinforcing the need to agnostically investigate miR-mRNA interactions and miR-regulated changes of protein content in the appropriate in vivo context.
